A Letter from the Director, August 2012
To our Patients, Families, Clinicians, and Researchers:
I would like to take this opportunity to welcome you back to our Director’s Update newsletter. The last few months have been a time of rapid growth and intense activity at the MCW Cancer Center, resulting in many significant accomplishments, including the opening of the centralized cancer Clinical Trials Office (CTO). This entire Director’s Update is dedicated to the CTO and the hard work of the staff, faculty, departments, and affiliates that built this important resource from the ground up. I want to personally thank and congratulate all of those involved with making the CTO a reality.
The Clinical Trials Office marks a key milestone in our process to become an NCI-designated Cancer Center, and reinforces MCW’s position as the area’s top cancer research and treatment destination. Many of today’s standard cancer treatments, treatments that prolong and improve quality of life, were first determined to be effective during a clinical trial. The CTO brings standardized processes and a single-minded focus that, ultimately, will allow us to conduct more clinical trials and enroll more patients.
In addition to our work on the CTO, we continue to evaluate and strengthen other Shared Resources at the MCW Cancer Center. These resources—labs, shared equipment, services, data, specialized knowledge, and dedicated staff—are a significant benefit of Cancer Center membership, and not otherwise available to an individual researcher because of cost, complexity, or lack of space. In upcoming newsletters, we will highlight our other Shared Resources and the impact these programs have on cancer research at MCW.
Future newsletters will also feature our Research Programs. These Programs continue to grow and expand and we will share Program news, membership, research initiatives, funding opportunities, and seminar speakers.
We continue to aggressively recruit both physician and basic scientists. I am proud to report that since I became Director in September 2010, we have recruited 27 cancer-related faculty members. Our membership roster continues to grow as well, and encourage anyone interested in cancer research to apply as soon as possible. Please visit our website to learn more about the membership application process and to apply to become a member of the MCW Cancer Center.
I am so encouraged and excited by the amazing growth I’ve seen in the past few months and by the many accomplishments made by our team. I hope you take a few minutes to read about the Clinical Trials Office and the impact the CTO will have on cancer research at MCW. If you have any questions or comments about the CTO or the MCW Caner Center, please contact me—my door is always open.
Ming You, MD, PhD